Early age at first childbirth associated with advanced tumor grade in breast cancer

Cancer Detection and Prevention

Volumn 32, Issue 3, 2008, Pages 215-223

  Veneroso, Carmela ^a   Siegel, Robert ^b   Levine, Paul H ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Aggressive; Breast cancer; Early age; First full term pregnancy; Hormones; Long term use; Oral contraceptives; Risk factor; Younger age diagnosis

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER RISK; CASE STUDY; CHILDBIRTH; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG USE; FEMALE; HISTOPATHOLOGY; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MEDICAL RECORD; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; REPRODUCTIVE HEALTH;

ADOLESCENT; ADULT; AGE OF ONSET; BREAST NEOPLASMS; CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; HUMANS; MATERNAL AGE; MIDDLE AGED; ODDS RATIO; PREGNANCY; RISK FACTORS;

EID: 52949107568     PISSN: 0361090X     EISSN: 15251500     Source Type: Journal    
DOI: 10.1016/j.cdp.2008.04.001     Document Type: Article

References (65)

1. Trudeau M.E., Pritchard K.I., Chapman J.A., Hanna W.M., Kahn H.J., Murray D., et al. Prognostic factors affecting the natural history of node-negative breast cancer. Breast Cancer Res Treat 89 1 (2005) 35-45
2. Bloom H. Prognosis in carcinoma of the breast. Br J Cancer 4 (1950) 259-288
3. Bloom H., and Richardson W. Histological grading and prognosis in breast cancer. Br J Cancer 11 (1957) 359-377
4. Fisher E.R., Redmond C., Fisher B., and Bass G. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Projects (NSABP). Prognostic discriminants for 8-year survival for node-negative invasive breast cancer patients. Cancer 65 9 Suppl. (1990) 2121-2128
5. Contesso G., Jotti G.S., and Bonadonna G. Tumor grade as a prognostic factor in primary breast cancer. Eur J Cancer Clin Oncol 25 3 (1989) 403-409
6. Davis B.W., Gelber R.D., Goldhirsch A., Hartmann W.H., Locher G.W., Reed R., et al. Prognostic significance of tumor grade in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis. Cancer 58 12 (1986) 2662-2670
7. Pinder S.E., Murray S., Ellis I.O., Trihia H., Elston C.W., Gelber R.D., et al. The importance of the histologic grade of invasive breast carcinoma and response to chemotherapy. Cancer 83 8 (1998) 1529-1539
8. Seshadri R., Horsfall D.J., McCaul K., and Leong A.S. A simple index to predict prognosis independent of axillary node information in breast cancer. Aust N Z J Surg 67 11 (1997) 765-770
9. Carriaga M.T., and Henson D.E. The histologic grading of cancer. Cancer 75 1 Suppl. (1995) 406-421
10. Freedman L.S., Edwards D.N., McConnell E.M., and Downham D.Y. Histological grade and other prognostic factors in relation to survival of patients with breast cancer. Br J Cancer 40 1 (1979) 44-55
11. Galea M.H., Blamey R.W., Elston C.E., and Ellis I.O. The Nottingham Prognostic Index in primary breast cancer. Breast Cancer Res Treat 22 3 (1992) 207-219
12. Elston C.W., and Ellis I.O. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19 5 (1991) 403-410
13. Saimura M., Fukutomi T., Tsuda H., Sato H., Miyamoto K., Akashi-Tanaka S., et al. Prognosis of a series of 763 consecutive node-negative invasive breast cancer patients without adjuvant therapy: analysis of clinicopathological prognostic factor. J Surg Oncol 71 2 (1999) 101-105
14. Okugawa H., Yamamoto D., Uemura Y., Sakaida N., Yamada M., Tanaka K., et al. Prognostic factors in breast cancer: the value of the Nottingham Prognostic Index for patients treated in a single institution. Surg Today 35 11 (2005) 907-911
15. Rosenberg J., Chia Y.L., and Plevritis S. The effect of age, race, tumor size, tumor grade, and disease stage on invasive ductal breast cancer survival in the U.S. SEER database. Breast Cancer Res Treat 89 1 (2005) 47-54
16. Porter G.J., Evans A.J., Pinder S.E., James J.J., Cornford E.C., Burrell H.C., et al. Patterns of metastatic breast carcinoma: influence of tumour histological grade. Clin Radiol 59 12 (2004) 1094-1098
17. Gerstman B.B., Gross T.P., Kennedy D.L., Bennett R.C., Tomita D.K., and Stadel B.V. Trends in the content and use of oral contraceptives in the United States, 1964-1988. Am J Public Health 81 1 (1991) 90-96
18. Oral contraceptives and breast cancer. Washington, DC: National Academy Press; 1991.
19. Chie W.C., Hsieh C., Newcomb P.A., Longnecker M.P., Mittendorf R., Greenberg E.R., et al. Age at any full-term pregnancy and breast cancer risk. Am J Epidemiol 151 7 (2000) 715-722
20. Largent J.A., Ziogas A., and Anton-Culver H. Effect of reproductive factors on stage, grade and hormone receptor status in early-onset breast cancer. Breast Cancer Res 7 4 (2005) R541-R554
21. Schouten L.J., Hupperets P.S., Jager J.J., Volovics L., Wils J.A., Verbeek A.L., et al. Prognostic significance of etiological risk factors in early breast cancer. Breast Cancer Res Treat 43 3 (1997) 217-223
22. Kroman N., Wohlfahrt J., Andersen K.W., Mouridsen H.T., Westergaard T., and Melbye M. Parity age at first childbirth and the prognosis of primary breast cancer. Br J Cancer 78 11 (1998) 1529-1533
23. Greenberg E.R., Vessey M.P., McPherson K., Doll R., and Yeates D. Body size and survival in premenopausal breast cancer. Br J Cancer 51 5 (1985) 691-697
24. Trivers K.F., Gammon M.D., Abrahamson P.E., Lund M.J., Flagg E.W., Kaufman J.S., et al. Association between reproductive factors and breast cancer survival in younger women. Breast Cancer Res Treat 103 1 (2007) 93-102
25. Chang S., Buzdar A.U., and Hursting S.D. Inflammatory breast cancer and body mass index. J Clin Oncol 16 12 (1998) 3731-3735
26. Mohle-Boetani J.C., Grosser S., Whittemore A.S., Malec M., Kampert J.B., and Paffenbarger Jr. R.S. Body size, reproductive factors, and breast cancer survival. Prev Med 17 5 (1988) 634-642
27. Morrison A.S., Lowe C.R., MacMachon B., Ravnihar B., and Yuasa S. Incidence risk factors survival in breast cancer: report on five years of follow-up observation. Eur J Cancer 13 3 (1977) 209-214
28. Lees A.W., Jenkins H.J., May C.L., Cherian G., Lam E.W., and Hanson J. Risk factors and 10-year breast cancer survival in northern Alberta. Breast Cancer Res Treat 13 2 (1989) 143-151
29. Lund E. Breast cancer mortality and the change in fertility risk factors at menopause: a prospective study of 800,000 married Norwegian women. Epidemiology 2 4 (1991) 285-288
30. Kelsey J.L., Gammon M.D., and John E.M. Reproductive factors and breast cancer. Epidemiol Rev 15 1 (1993) 36-47
31. Musey V.C., Collins D.C., Brogan D.R., Santos V.R., Musey P.I., Martino-Saltzman D., et al. Long term effects of a first pregnancy on the hormonal environment: estrogens and androgens. J Clin Endocrinol Metab 64 1 (1987) 111-118
32. Trichopoulos D., Cole P., Brown J.B., Goldman M.B., and MacMahon B. Estrogen profiles of primiparous and nulliparous women in Athens, Greece. J Natl Cancer Inst 65 1 (1980) 43-46
33. Cole P., MacMahon B., and Brown J.B. Oestrogen profiles of parous and nulliparous women. Lancet 2 7986 (1976) 596-599
34. Yu M.C., Gerkins V.R., Henderson B.E., Brown J.B., and Pike M.C. Elevated levels of prolactin in nulliparous women. Br J Cancer 43 6 (1981) 826-831
35. Musey V.C., Collins D.C., Musey P.I., Martino-Saltzman D., and Preedy J.R. Long-term effect of a first pregnancy on the secretion of prolactin. N Engl J Med 316 5 (1987) 229-234
36. Bernstein L., Pike M.C., Ross R.K., Judd H.L., Brown J.B., and Henderson B.E. Estrogen and sex hormone-binding globulin levels in nulliparous and parous women. J Natl Cancer Inst 74 4 (1985) 741-745
37. Bernstein L., Depue R.H., Ross R.K., Judd H.L., Pike M.C., and Henderson B.E. Higher maternal levels of free estradiol in first compared to second pregnancy: early gestational differences. J Natl Cancer Inst 76 6 (1986) 1035-1039
38. Hiraku Y., Yamashita N., Nishiguchi M., and Kawanishi S. Catechol estrogens induce oxidative DNA damage and estradiol enhances cell proliferation. Int J Cancer 92 3 (2001) 333-337
39. Preston-Martin S., Pike M.C., Ross R.K., Jones P.A., and Henderson B.E. Increased cell division as a cause of human cancer. Cancer Res 50 23 (1990) 7415-7421
40. Fernandez S.V., Russo I.H., and Russo J. Estradiol and its metabolites 4-hydroxyestradiol and 2-hydroxyestradiol induce mutations in human breast epithelial cells. Int J Cancer 118 8 (2006) 1862-1868
41. Yue W., Santen R.J., Wang J.P., Li Y., Verderame M.F., Bocchinfuso W.P., et al. Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis. J Steroid Biochem Mol Biol 86 3-5 (2003) 477-486
42. Devanesan P., Santen R.J., Bocchinfuso W.P., Korach K.S., Rogan E.G., and Cavalieri E. Catechol estrogen metabolites and conjugates in mammary tumors and hyperplastic tissue from estrogen receptor-alpha knock-out (ERKO)/Wnt-1 mice: implications for initiation of mammary tumors. Carcinogenesis 22 9 (2001) 1573-1576
43. Russo J., and Russo I.H. Toward a physiological approach to breast cancer prevention. Cancer Epidemiol Biomarkers Prev 3 4 (1994) 353-364
44. Land C.E., Tokunaga M., Koyama K., Soda M., Preston D.L., Nishimori I., et al. Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1990. Radiat Res 160 6 (2003) 707-717
45. Yang X., Edgerton S.M., Kosanke S.D., Mason T.L., Alvarez K.M., Liu N., et al. Hormonal and dietary modulation of mammary carcinogenesis in mouse mammary tumor virus-c-erbB-2 transgenic mice. Cancer Res 63 10 (2003) 2425-2433
46. Rosner D., Lane W.W., and Perez Brett R. Influence of oral contraceptives on the prognosis of breast cancer in young women. Cancer 55 7 (1985) 1556-1562
47. Rosner D.H., Joy J.V., and Lane W.W. Oral contraceptives and prognosis of breast cancer in women aged 35 to 50. J Surg Oncol 30 1 (1985) 52-59
48. Rosner D., and Lane W.W. Oral contraceptive use has no adverse effect on the prognosis of breast cancer. Cancer 57 3 (1986) 591-596
49. Schonborn I., Nischan P., and Ebeling K. Oral contraceptive use and the prognosis of breast cancer. Breast Cancer Res Treat 30 3 (1994) 283-292
50. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet 1996;347(9017):1713-27.
51. Sauerbrei W., Blettner M., Schmoor C., Bojar H., and Schumacher M. The effect of oral contraceptive use on the prognosis of node positive breast cancer patients. German Breast Cancer Study Group. Eur J Cancer 34 9 (1998) 1348-1351
52. Brinton L.A., Daling J.R., Liff J.M., Schoenberg J.B., Malone K.E., Stanford J.L., et al. Oral contraceptives and breast cancer risk among younger women. J Natl Cancer Inst 87 11 (1995) 827-835
53. Kay C.R., and Hannaford P.C. Breast cancer and the pill-a further report from the Royal College of General Practitioners' oral contraception study. Br J Cancer 58 5 (1988) 675-680
54. Olsson H., Borg A., Ferno M., Moller T.R., and Ranstam J. Early oral contraceptive use and premenopausal breast cancer-a review of studies performed in southern Sweden. Cancer Detect Prev 15 4 (1991) 265-271
55. de la Rochefordiere A., Asselain B., Campana F., Scholl S.M., Fenton J., Vilcoq J.R., et al. Age as prognostic factor in premenopausal breast carcinoma. Lancet 341 8852 (1993) 1039-1043
56. Walker R.A., Lees E., Webb M.B., and Dearing S.J. Breast carcinomas occurring in young women (<35 years) are different. Br J Cancer 74 11 (1996) 1796-1800
57. Bonnier P., Romain S., Charpin C., Lejeune C., Tubiana N., Martin P.M., et al. Age as a prognostic factor in breast cancer: relationship to pathologic and biologic features. Int J Cancer 62 2 (1995) 138-144
58. Kollias J., Elston C.W., Ellis I.O., Robertson J.F., and Blamey R.W. Early-onset breast cancer-histopathological and prognostic considerations. Br J Cancer 75 9 (1997) 1318-1323
59. Winchester D.P., Osteen R.T., and Menck H.R. The National Cancer Data Base report on breast carcinoma characteristics and outcome in relation to age. Cancer 78 8 (1996) 1838-1843
60. Gajdos C., Tartter P.I., Bleiweiss I.J., Bodian C., and Brower S.T. Stage 0 to stage III breast cancer in young women. J Am Coll Surg 190 5 (2000) 523-529
61. Kroman N., Wohlfahrt J., Andersen K.W., Mouridsen H.T., Westergaard T., and Melbye M. Time since childbirth and prognosis in primary breast cancer: population based study. BMJ 315 7112 (1997) 851-855
62. Leon D.A., Carpenter L.M., Broeders M.J., Gunnarskog J., and Murphy M.F. Breast cancer in Swedish women before age 50: evidence of a dual effect of completed pregnancy. Cancer Causes Control 6 4 (1995) 283-291
63. Bruzzi P., Negri E., La Vecchia C., Decarli A., Palli D., Parazzini F., et al. Short term increase in risk of breast cancer after full term pregnancy. BMJ 297 6656 (1988) 1096-1098
64. Guinee V.F., Olsson H., Moller T., Hess K.R., Taylor S.H., Fahey T., et al. Effect of pregnancy on prognosis for young women with breast cancer. Lancet 343 8913 (1994) 1587-1589
65. Henson D.E., Chu K.C., and Levine P.H. Histologic grade, stage, and survival in breast carcinoma: comparison of African American and Caucasian women. Cancer 98 5 (2003) 908-917